News and Events

Latest News

Arquer Diagnostics @Arquer Diagnostics
June is #ProstateCancerMonth, and #Arquer are at the forefront of this battle. We're working with many great #urologists to improve the pathway of #prostate #cancer #diagnostics. https://t.co/aL5eSKZmkj

- 7 days ago

1
Arquer Diagnostics @Arquer Diagnostics
#Arquer are pleased to confirm that we're attending #BAUS2019 - the British Annual Urology Society Meeting in Glasgow, on Jun 24-26th, where we'll be presenting #ADXBLADDER and meeting #urologists to create new alliances. https://t.co/j6srTBuKI8

- 10 days ago

1 1
Arquer Diagnostics @Arquer Diagnostics
What a privilege to speak at the Women in #Biopharma #Leadership event on 15 May, together with Jenny Rossiter! A group of talented, motivated and experienced women working together to further excellence in Biopharma. Until next time! #Arquer #lifesciences #cancer #oncology https://t.co/uvrF6NJnRf

- 19 days ago

2
Arquer Diagnostics @Arquer Diagnostics
We are proud to support @WorldBladderCan in their mission to provide #bladdercancer information worldwide, and build #medical alliances to improve #cancerpatient outcomes. https://t.co/pwETni8AUQ #bladdercanceraware #Arquer #ArquerDiagnostics #worldbladdercancer https://t.co/Hoy8GDPJFe

- 31 days ago

2
Arquer Diagnostics @Arquer Diagnostics
The results of our #ADXBLADDER are consistently excellent, proving the robustness of our non-invasive #cancer #diagnostics technology. #Urologists can now use this urine-based test to benefit patients worldwide. Click, to change #bladdercancer history: https://t.co/TtyefjKLku https://t.co/H8dDKHJvW8

- 40 days ago

1 1
arquer diagnostics

Innovation That Never Sleeps

The Start of Non-Invasive Testing When Arquer Diagnostics was set up to research and develop a new innovative urine test ...
Read More

Arquer Diagnostics achieves ISO13485 certification from BSI

In alignment with its commitment to achieving and maintaining excellence for patients, clinicians and all partners. BSI is an internationally ...
Read More

ADXBLADDER: A Novel Non-Invasive Aid for Bladder Cancer Monitoring

The innovative Arquer Diagnostic urine test for bladder cancer adds recurrence monitoring to the approved indications Sunderland, January 22nd 2019 ...
Read More

Arquer CEO Nadia Whittley Named Among Top 50 Female ‘Movers & Shakers’ in BioBusiness Report

Arquer Diagnostics Ltd (“Arquer”), a UK-based company focusing on the development of non-invasive cancer diagnostic tests today announced that CEO ...
Read More